Cannabis and Cardiovascular Health: Peer-Reviewed Research Consensus
Overview
The research base for cannabis and your body includes 213 peer-reviewed studies spanning 1975–2026. Of these, 21 provide strong evidence, including 7 meta-analyses and 7 randomized controlled trials. Key findings with strong support include: largest-ever meta-analysis (183m patients) found cannabis use significantly associated with stroke risk but not heart attack risk — though observational data can't prove causation, and meta-analysis of 81 million participants found cannabis use associated with 71% higher atrial arrhythmia risk, with concurrent drug use and legal country status further increasing risk. However, several findings remain debated, and the evidence is not uniform across all areas. Many studies have methodological limitations including small sample sizes, short follow-up periods, and reliance on self-reported data.
What the Research Shows
Findings supported by multiple peer-reviewed studies. Stronger evidence means more consistency across study types.
Largest-ever meta-analysis (183M patients) found cannabis use significantly associated with stroke risk but not heart attack risk — though observational data can't prove causation
Strong EvidenceMeta-analysis of 81 million participants found cannabis use associated with 71% higher atrial arrhythmia risk, with concurrent drug use and legal country status further increasing risk
Strong EvidenceMeta-analysis of 100+ million participants plus genetic analysis confirms cannabis use disorder is causally linked to stroke, particularly large artery stroke
Strong EvidenceWhere Scientists Disagree
Areas where research shows conflicting results or ongoing scientific debate.
A 1978 medical review identified cannabis as promising for glaucoma and asthma but flagged cardiovascular risks during exercise and preliminary concerns about lung and immune effects
Moderate EvidenceA major 1986 pharmacological review found cannabis's greatest health concern was its impact on youth development, while finding no proven brain damage and limited physical dependence in adults
Moderate EvidenceReview finding cannabis increases heart rate with rapid tolerance development, poses minimal risk for young healthy users but significant risks for people with existing cardiovascular disease
Moderate EvidenceReview comparing cardiovascular effects of five substance classes, finding cannabis posed fewer heart risks than opiates, amphetamines, or alcohol, though cognitive effects were noted
Moderate EvidenceWhat We Still Don't Know
- Only 7 randomized controlled trials exist out of 213 studies — most evidence is observational or from reviews.
- Long-term prospective studies tracking outcomes over 5+ years are largely absent from the literature.
- Research on diverse populations (different ages, ethnicities, and medical backgrounds) remains limited.
Evidence Breakdown
Distribution of study types in this research area. Higher-tier evidence (meta-analyses, RCTs) provides stronger conclusions.
Key Studies
The most impactful research in this area.
Cannabis, Cocaine, and Amphetamines All Linked to Higher Stroke Risk in Major Analysis
The Mendelian randomization component is crucial because it uses genetic variation to approximate a natural experiment, providing stronger evidence for causation than observational studies alone. Finding that cannabis use disorder is genetically linked to large artery stroke is a significant public
Cannabis use was associated with a 71% increased risk of atrial arrhythmias
As cannabis use expands globally, the cardiovascular risk profile is becoming clearer, and atrial arrhythmias represent a serious but potentially underrecognized consequence.
Cannabis and Heart Attack/Stroke Risk: A 183-Million-Patient Meta-Analysis Finds Stroke Risk but Not Heart Attack Risk
This is the largest meta-analysis of cannabis and cardiovascular risk ever conducted. With over 183 million patients, it has statistical power that individual studies lack. The finding that stroke risk is elevated while heart attack risk is not suggests cannabis may affect the cardiovascular system
JAMA's Comprehensive Review of What Cannabis Can and Can't Treat
A JAMA review represents the medical establishment's current consensus position. The fact that it was published in 2026 — years after most US states legalized some form of cannabis — signals that the medical community is still working to align clinical practice with evidence. The review's distinctio
Meta-Analysis Finds Cannabis Users Have Twice the Risk of Ischemic Stroke
Ischemic stroke among young adults is increasing globally, paralleling rising cannabis use. This meta-analysis provides the strongest pooled evidence to date that cannabis use approximately doubles stroke risk, a finding with particular relevance as legalization expands and cannabis is increasingly
Cannabis Users Had 48% Higher Risk of Cardiovascular Events in Large Meta-Analysis
Whether cannabis causes cardiovascular disease has been debated for years. This meta-analysis of nearly 1.9 million people provides the strongest pooled estimate to date, showing a significant association with composite cardiovascular events even if individual endpoints fall short of significance.
Research Timeline
How our understanding of this topic has evolved.
Pre-2000
6 studies published. Includes 2 RCTs.
2000–2009
9 studies published. Predominantly observational and review studies.
2010–2014
13 studies published. Predominantly observational and review studies.
2015–2019
43 studies published. Includes 1 RCTs, 1 strong-evidence studies.
2020–present
142 studies published. Includes 7 meta-analyses, 4 RCTs, 20 strong-evidence studies.
About This Consensus
This consensus synthesizes 213 peer-reviewed studies: 7 meta-analyses (3%), 7 randomized controlled trials (3%), 36 observational studies (17%), 54 reviews (25%), 43 case studies (20%), 66 other study types (31%). Studies span from the earliest available research through 2025. Evidence strength ratings reflect study design, sample size, and replication across multiple research groups.
This page synthesizes findings from 213 peer-reviewed studies. It is not medical advice. Always consult a healthcare provider for personal health decisions.
Read our guide: Cannabis and Cardiovascular Health →